Rheumatoid arthritis and the Arava (leflunomide) controversy.
Turkoski
Beatrice B
BB
Kent State University College of Nursing, Kent, OH, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D007555:Isoxazoles / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use*; D000077339:Leflunomide; D018579:Patient Selection; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide